Voyageur Pharmaceuticals Ltd. News
-
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
March 4, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) is pleased to…
-
Voyageur Clarifies Terms of Previously Announced Agreement
March 3, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”) wishes…
-
Voyageur Pharmaceuticals Grants Deferred Share Units
February 24, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative…
-
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
February 18, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) is pleased to…
-
Voyageur Receives $600K Grant from Alberta Innovates for Product Development
Voyageur receives $600,000 in funding through Alberta Innovates AICE-Market Access Program February 5, 2025 (Source) — Voyageur Pharmaceuticals…
-
Voyageur Secures $687k of Additional Capital from Warrant Exercises
Voyageur streamlines capitalization table through exercise of 5,725,829 warrants, expiry of 8,844,935 warrants Strong existing shareholder support, raising…
-
Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
LOI with Multinational Contrast Media Company Voyageur Introduced Five New Health Canada Licensed Barium Contrast Products Securing 1st…
-
Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch
January 13, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) is pleased to…
-
Voyageur Pharmaceuticals Ltd. Signs Letter of Intent with Global Contrast Imaging Company to Expand Market Reach and Product Portfolio
LOI Agreement is steppingstone to formal agreement, The Multinational Pharmaceutical company is ranked in the top five contrast…
-
Voyageur Announces Closing of Final Tranche of Private Placement
December 18, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Corporation”), is pleased…
